Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Practice Questions
  • Tweetorials
  • About

Posts by Juan Jose Gonzalez

Juan Jose Gonzalez

Juan Jose Gonzalez

Content Writer

@juanjgonMD
The Why? Series

Why do patients develop ascites after liver transplantation?

Ascites is a common complication of cirrhosis secondary to hemodynamic changes that cause systemic and splenic vasodilation as result of increased nitric oxide. The presence of ascites is associated...

Juan Jose Gonzalez

Juan Jose Gonzalez

March 17, 2024
Evidence Corner

What are the characteristics of the communities from where your liver transplant center receive referrals from?

https://journals.lww.com/lt/Fulltext/9900/Characterization_of_social_de…

Juan Jose Gonzalez

Juan Jose Gonzalez

September 25, 2023
The Why? Series

Why does hepatic encephalopathy develop after transjugular intrahepatic portosystemic (TIPS) shunt?

Transjugular intrahepatic portosystemic shunt (TIPS) has become a standard procedure for the treatment of portal hypertension complications. The most common indications include refractory ascites and...

Juan Jose Gonzalez

Juan Jose Gonzalez

February 20, 2023
The Why? Series

Why does alpha-1 antitrypsin deficiency cause liver disease?

Alpha-1 antitrypsin deficiency (A1AD) is caused by mutations in the SERPINA1 gene, which leads to decreased levels of alpha-1 antitrypsin (A1A), resulting in both lung and liver disease. The...

Juan Jose Gonzalez

Juan Jose Gonzalez

September 24, 2022

Subscribe

Enter your email here and receive monthly newsletters with new LFN material.

Registration failed. Please try again later.

Thanks for signing up!

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases